Fungal diagnostics in pneumonia

Seminars in Respiratory and Critical Care Medicine

Volumn 32, Issue 6, 2011, Pages 663-672

  Lease, Erika D ^a   Alexander, Barbara D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Fungal diagnosis; fungal tests; laboratory methods

Indexed keywords

ANTIGEN; BETA 1,3 GLUCAN; GALACTOMANNAN;

ARTICLE; DISEASE PREDISPOSITION; FUNGUS CULTURE; GENOMICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LUNG MYCOSIS; MICROSCOPY; MOLECULAR DIAGNOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; SERODIAGNOSIS;

CELL CULTURE TECHNIQUES; FUNGI; GENOMICS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG DISEASES, FUNGAL; MICROBIAL SENSITIVITY TESTS; MICROSCOPY; MYCOLOGICAL TYPING TECHNIQUES; PNEUMONIA; PROTEOMICS;

EID: 83655193178     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0031-1295714     Document Type: Article

References (75)

1. Marr K A., Carter R A., Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002 34 7 909-917 (Pubitemid 34229758)
2. De Pauw B, Walsh T J., Donnelly J P. et al, European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008 46 12 1813-1821
3. Murrary P R., Witebsky F G. The clinician and the microbiology lab. In: Mandell J L. Bennet J E. Dolin R eds. Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, PA Churchill Livingstone 2009 233-265
4. Harrington B J., Hageage G J. Calcofluor white: a review of its uses and applications in clinical mycology and parasitology. Lab Med 2003 34 361-367 (Pubitemid 36523254)
5. Bennet J E. Introduction to mycoses. In: Mandell J L. Bennet J E. Dolin R eds. Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, PA Churchill Livingstone 2009 3221-4
6. Procop G W., Haddad S, Quinn J et al. Detection of Pneumocystis jiroveci in respiratory specimens by four staining methods. J Clin Microbiol 2004 42 7 3333-3335 (Pubitemid 38938107)
7. Tarrand J J., Lichterfeld M, Warraich I et al. Diagnosis of invasive septate mold infections: a correlation of microbiological culture and histologic or cytologic examination. Am J Clin Pathol 2003 119 6 854-858 (Pubitemid 37047847)
8. Kontoyiannis D P., Wessel V C., Bodey G P., Rolston K V. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis 2000 30 6 851-856 (Pubitemid 32250321)
9. Alexander B D., Pfaller M A. Contemporary tools for the diagnosis and management of invasive mycoses. Clin Infect Dis 2006 43 S15-S27 (Pubitemid 44078893)
10. Balajee S A., Kano R, Baddley J W. et al. Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network. J Clin Microbiol 2009 47 10 3138-3141
11. Clinical and Laboratory Standards Institute (CLSI). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Approved Standard Third Edition. CLSI Document M27A3 (ISBN 1562386689). http://www.clsi.org Accessed July 25, 2011
12. Clinical and Laboratory Standards Institute (CLSI). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Approved Standard Second Edition. CLSI Document M38A2 (ISBN 1562386689). http://www.clsi.org Accessed July 25, 2011
13. Pfaller M A., Diekema D J., Ghannoum M A. et al, Clinical and Laboratory Standards Institute Antifungal Testing Subcommittee. Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods. J Clin Microbiol 2009 47 10 3142-3146
14. Reed J A., Hemann B A., Alexander J L., Brigati D J. Immunomycology: rapid and specific immunocytochemical identification of fungi in formalin-fixed, paraffin-embedded material. J Histochem Cytochem 1993 41 8 1217-1221 (Pubitemid 23220229)
15. Verweij P E., Smedts F, Poot T, Bult P, Hoogkamp-Korstanje J A., Meis J F. Immunoperoxidase staining for identification of Aspergillus species in routinely processed tissue sections. J Clin Pathol 1996 49 10 798-801 (Pubitemid 26338556)
16. Borchers A T., Gershwin M E. The immune response in Coccidioidomycosis. Autoimmun Rev 2010 10 2 94-102
17. Wheat J, Wheat H, Connolly P et al. Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses. Clin Infect Dis 1997 24 6 1169-1171 (Pubitemid 27249019)
18. Williams B, Fojtasek M, Connolly-Stringfield P, Wheat J. Diagnosis of histoplasmosis by antigen detection during an outbreak in Indianapolis, Ind. Arch Pathol Lab Med 1994 118 12 1205-1208 (Pubitemid 24373096)
19. Wheat L J., Conces D, Allen S D., Blue-Hnidy D, Loyd J. Pulmonary histoplasmosis syndromes: recognition, diagnosis, and management. Semin Respir Crit Care Med 2004 25 2 129-144 (Pubitemid 38544247)
20. Hage C A., Davis T E., Fuller D et al. Diagnosis of histoplasmosis by antigen detection in BAL fluid. Chest 2010 137 3 623-628
21. Blair J E., Coakley B, Santelli A C., Hentz J G., Wengenack N L. Serologic testing for symptomatic coccidioidomycosis in immunocompetent and immunosuppressed hosts. Mycopathologia 2006 162 5 317-324 (Pubitemid 44819314)
22. Sarosi G A., Lawrence J P., Smith D K., Thomas A, Hobohm D W., Kelley P C. Rapid diagnostic evaluation of bronchial washings in patients with suspected coccidioidomycosis. Semin Respir Infect 2001 16 4 238-241 (Pubitemid 34031645)
23. DiTommaso J P., Ampel N M., Sobonya R E., Bloom J W. Bronchoscopic diagnosis of pulmonary coccidioidomycosis: comparison of cytology, culture, and transbronchial biopsy. Diagn Microbiol Infect Dis 1994 18 2 83-87
24. Durkin M, Connolly P, Kuberski T et al. Diagnosis of coccidioidomycosis with use of the Coccidioides antigen enzyme immunoassay. Clin Infect Dis 2008 47 8 e69-e73
25. Fernandes V C., Coitinho J B., Veloso JMR, Araújo S A., Pedroso E P., Goes A M. Combined use of Paracoccidioides brasiliensis recombinant rPb27 and rPb40 antigens in an enzyme-linked immunosorbent assay for immunodiagnosis of paracoccidioidomycosis. J Immunol Methods 2011 367 1-2 78-84
26. Singh N, Alexander B D., Lortholary O et al. Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen. Clin Infect Dis 2008 46 2 e12-e18 (Pubitemid 351269182)
27. Kralovic S M., Rhodes J C. Utility of routine testing of bronchoalveolar lavage fluid for cryptococcal antigen. J Clin Microbiol 1998 36 10 3088-3089 (Pubitemid 28429449)
28. Lyman C A., Devi SJN, Nathanson J, Frasch C E., Pizzo P A., Walsh T J. Detection and quantitation of the glucuronoxylomannan-like polysaccharide antigen from clinical and nonclinical isolates of Trichosporon beigelii and implications for pathogenicity. J Clin Microbiol 1995 33 1 126-130 (Pubitemid 24382412)
29. Fekkar A, Brun S, DUssel M et al. Serum cross-reactivity with Aspergillus galactomannan and cryptococcal antigen during fatal disseminated Trichosporon dermatis infection. Clin Infect Dis 2009 49 9 1457-1458
30. Platelia aspergillus EIA [package insert]. Redmond, WA Bio-Rad Laboratories 2003
31. Pfeiffer C D., Fine J P., Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006 42 10 1417-1427
32. Park S Y., Lee S O., Choi S H. et al. Serum and bronchoalveolar lavage fluid galactomannan assays in patients with pulmonary aspergilloma. Clin Infect Dis 2011 52 7 e149-e152
33. Park S Y., Lee S O., Choi S H. et al. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J Infect 2010 61 6 492-498
34. Bergeron A, Belle A, Sulahian A et al. Contribution of galactomannan antigen detection in BAL to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies. Chest 2010 137 2 410-415
35. Nguyen M H., Leather H, Clancy C J. et al. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients. Biol Blood Marrow Transplant 2011 17 7 1043-1050
36. Meersseman W, Lagrou K, Maertens J et al. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med 2008 177 1 27-34
37. Maertens J, Maertens V, Theunissen K et al. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin Infect Dis 2009 49 11 1688-1693
38. Musher B, Fredricks D, Leisenring W, Balajee S A., Smith C, Marr K A. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J Clin Microbiol 2004 42 12 5517-5522 (Pubitemid 39664330)
39. Becker M J., Lugtenburg E J., Cornelissen J J., Van Der Schee C, Hoogsteden H C., De Marie S. Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. Br J Haematol 2003 121 3 448-457 (Pubitemid 36628336)
40. Pasqualotto A C., Xavier M O., Sánchez L B. et al. Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid. Transplantation 2010 90 3 306-311
41. Husain S, Clancy C J., Nguyen M H. et al. Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid. Clin Vaccine Immunol 2008 15 12 1760-1763
42. Sulahian A, Touratier S, Ribaud P. False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N Engl J Med 2003 349 24 2366-2367 (Pubitemid 37509754)
43. Adam O, Aupérin A, Wilquin F, Bourhis J H., Gachot B, Chachaty E. Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clin Infect Dis 2004 38 6 917-920 (Pubitemid 38387246)
44. Mattei D, Rapezzi D, Mordini N et al. False-positive Aspergillus galactomannan enzyme-linked immunosorbent assay results in vivo during amoxicillin-clavulanic acid treatment. J Clin Microbiol 2004 42 11 5362-5363 (Pubitemid 39506257)
45. Hage C A., Reynolds J M., Durkin M, Wheat L J., Knox K S. Plasmalyte as a cause of false-positive results for Aspergillus galactomannan in bronchoalveolar lavage fluid. J Clin Microbiol 2007 45 2 676-677
46. Marr K A., Laverdiere M, Gugel A, Leisenring W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis 2005 40 12 1762-1769 (Pubitemid 40799945)
47. Desmet S, Van Wijngaerden E, Maertens J et al. Serum (1-3) - D-glucan as a tool for diagnosis of Pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancy. J Clin Microbiol 2009 47 12 3871-3874
48. Yoshida M, Obayashi T, Iwama A et al. Detection of plasma (1 >3) - D-glucan in patients with Fusarium, Trichosporon, Saccharomyces and Acremonium fungaemias. J Med Vet Mycol 1997 35 5 371-374
49. Ostrosky-Zeichner L, Alexander B D., Kett D H. et al. Multicenter clinical evaluation of the (1>3) -D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005 41 5 654-659 (Pubitemid 41170353)
50. Odabasi Z, Mattiuzzi G, Estey E et al. -D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004 39 2 199-205 (Pubitemid 38971490)
51. Ostrosky-Zeichner L, Alexander B D., Kett D H. et al. Multicenter clinical evaluation of the (1>3) -D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005 41 5 654-659 (Pubitemid 41170353)
52. Pazos C, Pontón J, Del Palacio A. Contribution of (1->3) - D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol 2005 43 1 299-305 (Pubitemid 40096315)
53. Alexander B D., Smith P B., Davis R D., Perfect J R., Reller L B. The (1,3)-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation. J Clin Microbiol 2010 48 11 4083-4088
54. Pickering J W., Sant H W., Bowles C A., Roberts W L., Woods G L. Evaluation of a (1->3) - D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 2005 43 12 5957-5962 (Pubitemid 43100644)
55. Mennink-Kersten M A., Warris A, Verweij P E. 1,3 - D-glucan in patients receiving intravenous amoxicillin-clavulanic acid. N Engl J Med 2006 354 26 2834-2835 (Pubitemid 43974215)
56. Nakao A, Yasui M, Kawagoe T, Tamura H, Tanaka S, Takagi H. False-positive endotoxemia derives from gauze glucan after hepatectomy for hepatocellular carcinoma with cirrhosis. Hepatogastroenterology 1997 44 17 1413-1418 (Pubitemid 27450188)
57. Harrison E, Stalhberger T, Whelan R et al, Aspergillus Technology Consortium (AsTeC). Aspergillus DNA contamination in blood collection tubes. Diagn Microbiol Infect Dis 2010 67 4 392-394
58. Palmer J, Francesconi A, Kasai M et al. Sources of false positive Aspergillus DNA by PCR from normal human blood. Paper presented at: 41st Interscience Conference on Antimicrobial Agents and Chemotherapy; December 1619, 2001; Chicago, IL
59. Donnelly J P. Polymerase chain reaction for diagnosing invasive aspergillosis: getting closer but still a ways to go. Clin Infect Dis 2006 42 4 487-489 (Pubitemid 43202520)
60. Mengoli C, Cruciani M, Barnes R A., Loeffler J, Donnelly J P. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect Dis 2009 9 2 89-96
61. White P L., Perry M D., Moody A, Follett S A., Morgan G, Barnes R A. Evaluation of analytical and preliminary clinical performance of Myconostica MycAssay Aspergillus when testing serum specimens for diagnosis of invasive Aspergillosis. J Clin Microbiol 2011 49 6 2169-2174
62. Hayette M P., Vaira D, Susin F et al. Detection of Aspergillus species DNA by PCR in bronchoalveolar lavage fluid. J Clin Microbiol 2001 39 6 2338-2340 (Pubitemid 32531510)
63. Tuon F F. A systematic literature review on the diagnosis of invasive aspergillosis using polymerase chain reaction (PCR) from bronchoalveolar lavage clinical samples. Rev Iberoam Micol 2007 24 2 89-94 (Pubitemid 47025141)
64. Hauser P M., Bille J, Lass-Flörl C et al. Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assay. J Clin Microbiol 2011 49 5 1872-1878
65. Balajee S A., Kano R, Baddley J W. et al. Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network. J Clin Microbiol 2009 47 10 3138-3141
66. Hammond S P., Bialek R, Milner D A., Petschnigg E M., Baden L R., Marty F M. Molecular methods to improve diagnosis and identification of mucormycosis. J Clin Microbiol 2011 49 6 2151-2153
67. Rickerts V, Just-Nübling G, Konrad F et al. Diagnosis of invasive aspergillosis and mucormycosis in immunocompromised patients by seminested PCR assay of tissue samples. Eur J Clin Microbiol Infect Dis 2006 25 1 8-13 (Pubitemid 43207322)
68. Rickerts V, Mousset S, Lambrecht E et al. Comparison of histopathological analysis, culture, and polymerase chain reaction assays to detect invasive mold infections from biopsy specimens. Clin Infect Dis 2007 44 8 1078-1083 (Pubitemid 46580276)
69. Hayden R T., Qian X, Procop G W., Roberts G D., Lloyd R V. In situ hybridization for the identification of filamentous fungi in tissue section. Diagn Mol Pathol 2002 11 2 119-126 (Pubitemid 34538805)
70. Hayden R T., Isotalo P A., Parrett T et al. In situ hybridization for the differentiation of Aspergillus, Fusarium, and Pseudallescheria species in tissue section. Diagn Mol Pathol 2003 12 1 21-26 (Pubitemid 36255266)
71. Gonzales D A., De Torre C, Wang H et al. Protein expression profiles distinguish between experimental invasive pulmonary aspergillosis and Pseudomonas pneumonia. Proteomics 2010 10 23 4270-4280
72. Sainz J, Salas-Alvarado I, López-Fernández E et al. TNFR1 mRNA expression level and TNFR1 gene polymorphisms are predictive markers for susceptibility to develop invasive pulmonary aspergillosis. Int J Immunopathol Pharmacol 2010 23 2 423-436
73. Loeffler J, Ok M, Morton O C., Mezger M, Einsele H. Genetic polymorphisms in the cytokine and chemokine system: their possible importance in allogeneic stem cell transplantation. Curr Top Microbiol Immunol 2010 341 83-96
74. Zaas A K., Liao G, Chien J W. et al. Plasminogen alleles influence susceptibility to invasive aspergillosis. PLoS Genet 2008 4 6 e1000101
75. Bochud P Y., Chien J W., Marr K A. et al. Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N Engl J Med 2008 359 17 1766-1777